A tissue engineered blood vessel model of Hutchinson-Gilford Progeria syndrome using Human iPSC-derived smooth muscle cellsPost author:caolab75@gmail.comPost published:August 15, 2017Post category:Articless41598-017-08632-4 You Might Also Like In vivo base editing rescues Hutchinson–Gilford progeria syndrome in mice January 6, 2021 Methylene blue alleviates nuclear and mitochondrial abnormalities in progeria November 5, 2015 A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model. August 15, 2008
A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model. August 15, 2008
